EDGAR Filing Documents for 0001354488-15-003377

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001354488-15-003377

Filing Date

2015-07-20

Accepted

2015-07-20 07:48:34

Documents

Period of Report

2015-06-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDED CURENT REPORT	tbuff_8ka.htm	8-K/A	91406
2	CONSENT OF MCGOVERN, HURLEY, CUNNINGHAM, LLP	tbuff_ex231.htm	EX-23.1	2872
3	AUDITED FINANCIAL STATEMENTS OF MEDICAL FUTURES INC. AS OF DECEMBER 31, 2014 AND	tbuff_ex992.htm	EX-99.2	356837
4	UNAUDITED FINANCIAL STATEMENTS OF MEDICAL FUTURES INC. AS OF MARCH 31, 2015 AND	tbuff_ex993.htm	EX-99.3	1755
5		ex993_page1.jpg	GRAPHIC	25217
6		ex993_page2.jpg	GRAPHIC	27553
7		ex992_page03.jpg	GRAPHIC	74425
	Complete submission text file	0001354488-15-003377.txt		630097

Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8

Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540

Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)